Effects of an Accelerated Intravenous Iron Regimen in Hospitalized Patients With Advanced Heart Failure and Iron Deficiency

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Pharmacotherapy

• Publication date

  2015-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/phar.1525PMID 25556867
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Distinguishing Anemia and Iron Deficiency of Heart Failure: Signal for Severity of Disease or Unmet Therapeutic Need?

  2014cited by this paper
• Treatment of anemia with darbepoetin alfa in systolic heart failure.

  2013influential reference
• Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives

  2012cited by this paper
• Iron deficiency: an ominous sign in patients with systolic chronic heart failure.

  2010cited by this paper
• Report from a consensus conference on the sensitized patient awaiting heart transplantation.

  2009cited by this paper
• Ferric carboxymaltose in patients with heart failure and iron deficiency.

  2009influential reference
• Evaluation of total-dose iron sucrose infusions in patients with iron deficiency anemia.

  2008cited by this paper
• Anemia and mortality in heart failure patients a systematic review and meta-analysis.

  2008cited by this paper
• Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency.

  2008cited by this paper
• Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry).

  2008cited by this paper
• Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial.

  2008cited by this paper
• Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.

  2007cited by this paper
• Intravenous iron alone for the treatment of anemia in patients with chronic heart failure.

  2006cited by this paper
• Update on adverse drug events associated with parenteral iron.

  2006cited by this paper
• Chronic use of sodium ferric gluconate complex in hemodialysis patients: safety of higher-dose (> or =250 mg) administration.

  2003cited by this paper
• Hemodilution Is Common in Patients With Advanced Heart Failure

  2003cited by this paper
• Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure.

  2003cited by this paper
• The safety and efficacy of an accelerated iron sucrose dosing regimen in patients with chronic kidney disease.

  2003cited by this paper
• Weekly administration of high-dose sodium ferric gluconate is safe and effective in peritoneal dialysis patients.

  2002cited by this paper
• A randomized, controlled parallel-group trial on efficacy and safety of iron sucrose (Venofer) vs iron gluconate (Ferrlecit) in haemodialysis patients treated with rHuEpo.

  2001cited by this paper
• [Intravenous iron-dextran: therapeutic and experimental possibilities].

  1970cited by this paper

• Evaluation of a Pharmacist-Led Intravenous Iron Therapy Transitions of Care Service in Heart Failure.

  2025cites this paper
• Management of Iron Deficiency in Heart Failure: Practical Considerations and Implementation of Evidence-Based Iron Supplementation.

  2024cites this paper
• Intravenous iron in patients with iron deficiency and heart failure: a review of modern evidence

  2024cites this paper
• Safety of an Accelerated Ferric Gluconate Inpatient Infusion Regimen

  2024cites this paper
• Dark Red Urine in a Patient on Cefiderocol and Ferric Gluconate

  2022cites this paper
• Heart Failure

  2022cites this paper
• Safety and Efficacy of Early Post-Operative Intravenous Iron Replacement In Patients With HeartMate III Left Ventricular Assist Device

  2022cites this paper
• Management of Iron Deficiency in Heart Failure: A Review of Evidence

  2022cites this paper
• Intravenous iron for heart failure with evidence of iron deficiency: a meta-analysis of randomised trials

  2021cites this paper
• Management of noncardiovascular comorbidities in patients with heart failure with reduced ejection fraction

  2021cites this paper
• Safety and Effectiveness of an Accelerated Intravenous Iron Administration Protocol in Hospitalized Patients With Heart Failure

  2021cites this paper
• Recent and Emerging Therapies for Iron Deficiency in Anemia of CKD: A Review.

  2021cites this paper
• Eficacia y seguridad del uso de hierro en el tratamiento de la falla cardiaca: revisión sistemática

  2019cites this paper
• Intravenous Versus Oral Iron Replacement in Patients with a Continuous-Flow Left Ventricular Assist Device.

  2019cites this paper
• Differences between intravenous iron products: focus on treatment of iron deficiency in chronic heart failure patients

  2019cites this paper
• Iron Deficiency in Heart Failure

  2019cites this paper
• Iron deficiency in chronic and acute heart failure: A contemporary review on intertwined conditions.

  2018cites this paper
• Investigation and treatment for iron deficiency in heart failure: the unmet need in Lower and Middle Income Countries

  2017cites this paper
• Towards Holistic Heart Failure Management—How to Tackle the Iron Deficiency Epidemic?

  2017cites this paper
• Iron Deficiency Treatment in Patients with Heart Failure.

  2017cites this paper
• Anaemia and iron deficiency in heart failure: epidemiological gaps, diagnostic challenges and therapeutic barriers in sub-Saharan Africa

  2017cites this paper
• Iron Therapy in Patients with Heart Failure and Iron Deficiency: Review of Iron Preparations for Practitioners

  2016cites this paper
• Heart failure and anemia in Sub-Saharan Africa : etiology, characterization, prognosis and the role of oral iron – experiences from Tanzania

  2016cites this paper
• Effects of Total Dose Infusion of Iron Intravenously in Patients With Acute Heart Failure and Anemia (Hemoglobin < 13 g/dl).

  2016cites this paper
• Efficacy, safety and prognostic benefit of intravenous iron therapy with ferric carboxymaltose in patients with heart failure and left ventricular dysfunction.

  2016cites this paper
• Effects of intravenous iron therapy in patients with heart failure with iron deficiency

  year unknowncites this paper